FDA Announces Proposed Collection of Information for Individual Patient Expanded Access Applications

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as part of its guidance for industry on individual patient expanded access applications, as outlined in Form FDA 3926.